Mechanisms of Action of the KCa2-Negative Modulator AP30663, a Novel Compound in Development for Treatment of Atrial Fibrillation in Man
暂无分享,去创建一个
L. Folkersen | U. Sørensen | M. Grunnet | B. Bentzen | S. H. Bomholtz | T. Speerschneider | L. Abildgaard | N. Edvardsson | K. Muthukumarasamy | R. Simó-Vicens | J. G. Diness